Status:
COMPLETED
Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy
Lead Sponsor:
Sung Kwang Medical Foundation
Conditions:
Cerebral Palsy
Eligibility:
All Genders
10-10 years
Phase:
NA
Brief Summary
This randomized control study is aimed to determine efficacy of umbilical cord blood and erythropoietin combination therapy for children with cerebral palsy.
Detailed Description
Cerebral palsy is a disorder of movement and posture that result from a nonprogressive lesion or injury of the immature brain. It is a leading cause of childhood onset disability through one's life. U...
Eligibility Criteria
Inclusion
- Known cerebral palsy
- Willing to comply with all study procedure
Exclusion
- High risk of pneumonia or renal function deterioration after using of immunosuppressant
- Presence of known genetic disease
- Possibility of drug hypersensitivity which is related to this study remedy
- History of previous cell therapy
- Poor cooperation of guardian,including inactive attitude for rehabilitation
- Intractable seizure disorder
- Autism
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT01193660
Start Date
May 1 2010
End Date
April 1 2011
Last Update
November 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea